The store will not work correctly when cookies are disabled.
2-Chloro-N-(4-(3-(2-methoxyethoxy)-5-(thiophen-2-yl)-1H-1,2,4-triazol-1-yl)phenyl)acetamide
ID: ALA4129963
PubChem CID: 145962049
Max Phase: Preclinical
Molecular Formula: C17H17ClN4O3S
Molecular Weight: 392.87
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COCCOc1nc(-c2cccs2)n(-c2ccc(NC(=O)CCl)cc2)n1
Standard InChI: InChI=1S/C17H17ClN4O3S/c1-24-8-9-25-17-20-16(14-3-2-10-26-14)22(21-17)13-6-4-12(5-7-13)19-15(23)11-18/h2-7,10H,8-9,11H2,1H3,(H,19,23)
Standard InChI Key: BSXMVSQRYNARHI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
17.8915 -17.6357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7087 -17.6357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.9631 -16.8590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3001 -16.3768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6414 -16.8590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4109 -18.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5973 -18.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1163 -18.8649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4476 -19.6129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2647 -19.6972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7421 -19.0365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7406 -16.6075 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3471 -17.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1247 -16.9037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7312 -17.4514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5088 -17.1999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9673 -20.2740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1546 -20.1886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6743 -20.8497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8222 -19.4421 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8616 -20.7643 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.8611 -16.6080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6082 -15.8310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7910 -15.8313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5388 -16.6087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2002 -17.0886 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
1 6 1 0
3 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
9 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 1 0
5 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 392.87 | Molecular Weight (Monoisotopic): 392.0710 | AlogP: 3.20 | #Rotatable Bonds: 8 |
Polar Surface Area: 78.27 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.42 | CX LogD: 3.42 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.47 | Np Likeness Score: -2.20 |
References
1. Wu G, Wang H, Zhou W, Zeng B, Mo W, Zhu K, Liu R, Zhou J, Chen C, Chen H.. (2018) Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors., 26 (12): [PMID:29751989] [10.1016/j.bmc.2018.04.059] |